2.28
+0.02(+0.89%)
Currency In USD
| Previous Close | 2.26 |
| Open | 2.23 |
| Day High | 2.29 |
| Day Low | 2.21 |
| 52-Week High | 2.63 |
| 52-Week Low | 1.51 |
| Volume | 169,421 |
| Average Volume | 231,865 |
| Market Cap | 134.44M |
| PE | -1.75 |
| EPS | -1.3 |
| Moving Average 50 Days | 2.38 |
| Moving Average 200 Days | 1.99 |
| Change | 0.02 |
If you invested $1000 in Seer, Inc. (SEER) since IPO date, it would be worth $40.38 as of February 05, 2025 at a share price of $2.28. Whereas If you bought $1000 worth of Seer, Inc. (SEER) shares 3 years ago, it would be worth $137.43 as of February 05, 2025 at a share price of $2.28.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Seer to Present at the J.P. Morgan 43rd Annual Healthcare Conference
GlobeNewswire Inc.
Jan 02, 2025 9:05 PM GMT
REDWOOD CITY, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be participating in the upcoming J.P.
Seer Ranked Number 57 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™
GlobeNewswire Inc.
Nov 21, 2024 9:05 PM GMT
Attributes 2,440% revenue growth to increased adoption of its Proteograph™ Product Suite and exciting discoveries made by Seer customers across multiple areas of biology and diseaseREDWOOD CITY, Calif., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Seer, Inc.
Seer to Participate in Upcoming November Investor Conferences
GlobeNewswire Inc.
Nov 08, 2024 12:00 PM GMT
REDWOOD CITY, Calif., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced company management will be participating in the following investor